MapLight Therapeutics, Inc. (MLPT) — real insider trading activity disclosed to the SEC, tracked automatically as new Form 4 filings are reported. Most recent: Catalyst4, Inc. disclosed a transaction on 2026-08-14 worth $50,072,000.
Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Catalyst4, Inc. | Insider | 2026-08-14 | 4,400,000 | $50,072,000 |
| Catalyst4, Inc. | Insider | 2026-07-30 | 1,000,000 | $13,000,000 |
| Catalyst4, Inc. | Insider | 2026-07-29 | 3,000 | $37,890 |
| Catalyst4, Inc. | Insider | 2026-07-28 | 141,088 | $1,515,511 |
| Catalyst4, Inc. | Insider | 2026-07-28 | 65,137 | $761,393 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
Catalyst4, Inc., an insider at MapLight Therapeutics, Inc. (MLPT), disclosed a fresh open-market purchase in a Form 4 filing with the SEC. The transaction, dated August 14, 2026, shows Catalyst4 buying 4,400,000 shares at $11.38 apiece, a total outlay of $50,072,000.00 paid with the insider’s own funds. Following the purchase, Catalyst4 reports beneficial ownership of … Read more
MapLight Therapeutics, Inc. (MLPT) is drawing attention this week after a fresh Form 4 filing showed insider entity Catalyst4, Inc. purchasing 1,000,000 shares of the company on the open market on July 30, 2026. The purchase price came to $13.00 per share, for a total outlay of $13,000,000.00 — money spent directly by the insider, … Read more